MESIAL TEMPORAL LOBE EPILEPSY
Clinical trials for MESIAL TEMPORAL LOBE EPILEPSY explained in plain language.
Never miss a new study
Get alerted when new MESIAL TEMPORAL LOBE EPILEPSY trials appear
Sign up with your email to follow new studies for MESIAL TEMPORAL LOBE EPILEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain cell implant trial offers new hope for untreatable epilepsy
Disease control Recruiting nowThis study is testing whether implanting specially engineered brain cells into the seizure area can safely reduce or stop seizures in adults with epilepsy that doesn't respond to medications. Participants receive a one-time brain injection of these cells, which are designed to ca…
Matched conditions: MESIAL TEMPORAL LOBE EPILEPSY
Phase: PHASE3 • Sponsor: Neurona Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Brain gene therapy trial offers hope for untreatable epilepsy
Disease control Recruiting nowThis first-in-human study is testing whether a new gene therapy called AMT-260 can safely reduce seizures in adults with drug-resistant temporal lobe epilepsy. All 12 participants will receive a single dose delivered directly to the brain using advanced MRI guidance, without remo…
Matched conditions: MESIAL TEMPORAL LOBE EPILEPSY
Phase: PHASE1, PHASE2 • Sponsor: UniQure Biopharma B.V. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC